Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/18/21
09/18
04:55
09/18/21
04:55
ABBV

AbbVie

$107.75 /

-0.33 (-0.31%)

, AYLA

Ayala Pharmaceuticals

$12.25 /

-0.01 (-0.08%)

, DCPH

Deciphera

$33.08 /

+1.45 (+4.58%)

, GMAB

Genmab

$43.10 /

+0.845 (+2.00%)

, LPTX

Leap Therapeutics

$2.65 /

+0.13 (+5.16%)

, ORIC

Oric Pharmaceuticals

$25.20 /

+0.99 (+4.09%)

, SYNH

Syneos Health

$94.34 /

+0.55 (+0.59%)

, BGNE

BeiGene

$403.60 /

+18.32 (+4.75%)

, BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

, BYSI

BeyondSpring

$23.00 /

+0.47 (+2.09%)

, CALA

Calithera Biosciences

$2.25 /

+0.2 (+9.76%)

, GILD

Gilead

$71.61 /

+0.34 (+0.48%)

, GH

Guardant Health

$132.01 /

+5.01 (+3.94%)

, LLY

Eli Lilly

$230.17 /

-0.78 (-0.34%)

, IPSEY

Ipsen

$23.92 /

-0.395 (-1.62%)

, EXAS

Exact Sciences

$108.29 /

+5.47 (+5.32%)

, IDYA

Ideaya Biosciences

$26.90 /

+0.9 (+3.46%)

, GSK

GlaxoSmithKline

$38.94 /

-0.16 (-0.41%)

, RHHBY

Roche

$46.07 /

-0.75 (-1.60%)

, REGN

Regeneron

$651.38 /

-2.3 (-0.35%)

, PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

, TMO

Thermo Fisher

$596.98 /

+36.11 (+6.44%)

, TCRR

TCR2 Therapeutics

$10.00 /

-5.715 (-36.38%)

, VERU

Veru

$8.94 /

+0.17 (+1.94%)

, VBLT

VBL Therapeutics

$2.32 /

-0.035 (-1.49%)

, VTRS

Viatris

$13.57 /

-0.13 (-0.95%)

, NVS

Novartis

$83.49 /

-0.88 (-1.04%)

ESMO 2021 Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$43.10 /

+0.845 (+2.00%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.61 /

+0.34 (+0.48%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$132.01 /

+5.01 (+3.94%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$23.92 /

-0.395 (-1.62%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.07 /

-0.75 (-1.60%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$651.38 /

-2.3 (-0.35%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

09/17/21 Wedbush
TCR2 Therapeutics downgraded to Neutral from Outperform at Wedbush
08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
VERU Veru
$8.94 /

+0.17 (+1.94%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.57 /

-0.13 (-0.95%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$83.49 /

-0.88 (-1.04%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

AYLA Ayala Pharmaceuticals
$12.25 /

-0.01 (-0.08%)

DCPH Deciphera
$33.08 /

+1.45 (+4.58%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

CALA Calithera Biosciences
$2.25 /

+0.2 (+9.76%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VBLT VBL Therapeutics
$2.32 /

-0.035 (-1.49%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

SYNH Syneos Health
$94.34 /

+0.55 (+0.59%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

GMAB Genmab
$43.10 /

+0.845 (+2.00%)

LPTX Leap Therapeutics
$2.65 /

+0.13 (+5.16%)

ORIC Oric Pharmaceuticals
$25.20 /

+0.99 (+4.09%)

BGNE BeiGene
$403.60 /

+18.32 (+4.75%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

GH Guardant Health
$132.01 /

+5.01 (+3.94%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

EXAS Exact Sciences
$108.29 /

+5.47 (+5.32%)

IDYA Ideaya Biosciences
$26.90 /

+0.9 (+3.46%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

RHHBY Roche
$46.07 /

-0.75 (-1.60%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

TCRR TCR2 Therapeutics
$10.00 /

-5.715 (-36.38%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

NVS Novartis
$83.49 /

-0.88 (-1.04%)

ABBV AbbVie
$107.75 /

-0.33 (-0.31%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BYSI BeyondSpring
$23.00 /

+0.47 (+2.09%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

LLY Eli Lilly
$230.17 /

-0.78 (-0.34%)

GSK GlaxoSmithKline
$38.94 /

-0.16 (-0.41%)

REGN Regeneron
$651.38 /

-2.3 (-0.35%)

PFE Pfizer
$43.89 /

-0.57 (-1.28%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

TMO Thermo Fisher
$596.98 /

+36.11 (+6.44%)

VERU Veru
$8.94 /

+0.17 (+1.94%)

VTRS Viatris
$13.57 /

-0.13 (-0.95%)

Yesterday
Recommendations
KLA Corp. price target raised to $450 from $425 at BofA » 06:28
09/17/21
09/17
06:28
09/17/21
06:28
KLAC

KLA Corp.

$372.00 /

+4.66 (+1.27%)

BofA analyst Vivek Arya…

BofA analyst Vivek Arya raised the firm's price target on KLA Corp. to $450 from $425 and keeps a Buy rating on the shares. The analyst remains "firmly in the stronger-for-longer camp" for semiconductors given their "critical role in the rapidly digitizing global economy." The companies face "newfound pricing power and supply discipline" with a "very lean supply chain," Arya tells investors in a research note. The analyst calls KLA his top pick. .

ShowHide Related Items >><<
KLAC KLA Corp.
$372.00 /

+4.66 (+1.27%)

KLAC KLA Corp.
$372.00 /

+4.66 (+1.27%)

09/14/21
Fly Intel: Top five analyst upgrades
09/14/21 Susquehanna
KLA upgraded to Positive with $475 price target at Susquehanna
09/14/21 Susquehanna
KLA Corp. upgraded to Positive from Neutral at Susquehanna
08/03/21 Citi
Citi moves up KLA to number two pick in semiconductors
KLAC KLA Corp.
$372.00 /

+4.66 (+1.27%)

KLAC KLA Corp.
$372.00 /

+4.66 (+1.27%)

KLAC KLA Corp.
$372.00 /

+4.66 (+1.27%)

Hot Stocks
Amazon.com says over 1M people applied for jobs at Career Day 2021 » 06:01
09/17/21
09/17
06:01
09/17/21
06:01
AMZN

Amazon.com

$3,488.13 /

+13.34 (+0.38%)

Amazon announced that…

Amazon announced that over 1M people applied for a job at Amazon as part of Career Day 2021. The virtual event attracted job seekers from more than 170 countries around the world. In the span of 24 hours, more than 2,000 Amazon recruiters offered 30,000 individual career coaching sessions with participants. The recruiters provided job seekers with professional advice to start, transition, or grow their careers-whether they wanted to work at Amazon or elsewhere.

ShowHide Related Items >><<
AMZN Amazon.com
$3,488.13 /

+13.34 (+0.38%)

AMZN Amazon.com
$3,488.13 /

+13.34 (+0.38%)

09/14/21 Evercore ISI
Amazon price target raised to $4,700 from $4,200 at Evercore ISI
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Amazon.com initiated with a Buy at Goldman Sachs
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
AMZN Amazon.com
$3,488.13 /

+13.34 (+0.38%)

AMZN Amazon.com
$3,488.13 /

+13.34 (+0.38%)

AMZN Amazon.com
$3,488.13 /

+13.34 (+0.38%)

AMZN Amazon.com
$3,488.13 /

+13.34 (+0.38%)

Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
ABBV

AbbVie

$108.08 /

+0.29 (+0.27%)

, AYLA

Ayala Pharmaceuticals

$12.26 /

-1.76 (-12.55%)

, DCPH

Deciphera

$31.77 /

+0.72 (+2.32%)

, GMAB

Genmab

$42.26 /

-0.575 (-1.34%)

, LPTX

Leap Therapeutics

$2.52 /

+0.57 (+29.23%)

, ORIC

Oric Pharmaceuticals

$24.49 /

-0.31 (-1.25%)

, SYNH

Syneos Health

$93.78 /

+0.07 (+0.07%)

, BGNE

BeiGene

$385.26 /

+10.94 (+2.92%)

, BMY

Bristol-Myers

$61.22 /

-0.78 (-1.26%)

, BYSI

BeyondSpring

$22.50 /

-0.48 (-2.09%)

, CALA

Calithera Biosciences

$2.05 /

-0.04 (-1.91%)

, GILD

Gilead

$71.32 /

-0.45 (-0.63%)

, GH

Guardant Health

$127.00 /

-0.01 (-0.01%)

, LLY

Eli Lilly

$230.95 /

-2.72 (-1.16%)

, IPSEY

Ipsen

$24.32 /

+0.23 (+0.95%)

, EXAS

Exact Sciences

$102.81 /

-1.83 (-1.75%)

, IDYA

Ideaya Biosciences

$25.90 /

-0.1 (-0.38%)

, GSK

GlaxoSmithKline

$39.10 /

-0.11 (-0.28%)

, RHHBY

Roche

$46.82 /

-0.04 (-0.09%)

, REGN

Regeneron

$652.73 /

+2.13 (+0.33%)

, PFE

Pfizer

$44.46 /

-0.31 (-0.69%)

, TAK

Takeda Pharmaceutical

$17.21 /

+0.205 (+1.21%)

, TMO

Thermo Fisher

$560.75 /

-2.085 (-0.37%)

, TCRR

TCR2 Therapeutics

$15.71 /

-0.51 (-3.14%)

, VERU

Veru

$8.76 /

-0.04 (-0.45%)

, VBLT

VBL Therapeutics

$2.35 /

+0.055 (+2.40%)

, VTRS

Viatris

$13.70 /

-0.03 (-0.22%)

, NVS

Novartis

$84.37 /

-0.695 (-0.82%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.70 /

-0.03 (-0.22%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

IPSEY Ipsen
$24.32 /

+0.23 (+0.95%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GMAB Genmab
$42.26 /

-0.575 (-1.34%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$42.26 /

-0.575 (-1.34%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.32 /

-0.45 (-0.63%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$127.00 /

-0.01 (-0.01%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$24.32 /

+0.23 (+0.95%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.82 /

-0.04 (-0.09%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$652.73 /

+2.13 (+0.33%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$44.46 /

-0.31 (-0.69%)

09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/13/21 JPMorgan
Pfizer price target raised to $42 from $40 at JPMorgan
TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
VERU Veru
$8.76 /

-0.04 (-0.45%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.70 /

-0.03 (-0.22%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$84.37 /

-0.695 (-0.82%)

09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
VTRS Viatris
$13.70 /

-0.03 (-0.22%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

VBLT VBL Therapeutics
$2.35 /

+0.055 (+2.40%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

DCPH Deciphera
$31.77 /

+0.72 (+2.32%)

CALA Calithera Biosciences
$2.05 /

-0.04 (-1.91%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

AYLA Ayala Pharmaceuticals
$12.26 /

-1.76 (-12.55%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

SYNH Syneos Health
$93.78 /

+0.07 (+0.07%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

BGNE BeiGene
$385.26 /

+10.94 (+2.92%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

TMO Thermo Fisher
$560.75 /

-2.085 (-0.37%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

ORIC Oric Pharmaceuticals
$24.49 /

-0.31 (-1.25%)

NVS Novartis
$84.37 /

-0.695 (-0.82%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

IDYA Ideaya Biosciences
$25.90 /

-0.1 (-0.38%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GMAB Genmab
$42.26 /

-0.575 (-1.34%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

GH Guardant Health
$127.00 /

-0.01 (-0.01%)

EXAS Exact Sciences
$102.81 /

-1.83 (-1.75%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

VTRS Viatris
$13.70 /

-0.03 (-0.22%)

VERU Veru
$8.76 /

-0.04 (-0.45%)

TAK Takeda Pharmaceutical
$17.21 /

+0.205 (+1.21%)

REGN Regeneron
$652.73 /

+2.13 (+0.33%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

LLY Eli Lilly
$230.95 /

-2.72 (-1.16%)

GSK GlaxoSmithKline
$39.10 /

-0.11 (-0.28%)

GILD Gilead
$71.32 /

-0.45 (-0.63%)

BYSI BeyondSpring
$22.50 /

-0.48 (-2.09%)

BMY Bristol-Myers
$61.22 /

-0.78 (-1.26%)

ABBV AbbVie
$108.08 /

+0.29 (+0.27%)

Thursday
Conference/Events
European Society for Medical Oncology to hold a virtual meeting » 10:09
09/16/21
09/16
10:09
09/16/21
10:09
ABBV

AbbVie

$107.05 /

-0.74 (-0.69%)

, AYLA

Ayala Pharmaceuticals

$14.30 /

+0.28 (+2.00%)

, DCPH

Deciphera

$30.40 /

-0.65 (-2.09%)

, GMAB

Genmab

$42.26 /

-0.57 (-1.33%)

, LPTX

Leap Therapeutics

$2.34 /

+0.39 (+20.00%)

, ORIC

Oric Pharmaceuticals

$25.02 /

+0.22 (+0.89%)

, SYNH

Syneos Health

$93.28 /

-0.43 (-0.46%)

, BGNE

BeiGene

$377.63 /

+3.31 (+0.88%)

, BMY

Bristol-Myers

$61.18 /

-0.82 (-1.32%)

, BYSI

BeyondSpring

$22.25 /

-0.73 (-3.18%)

, CALA

Calithera Biosciences

$2.06 /

-0.03 (-1.44%)

, GILD

Gilead

$71.34 /

-0.43 (-0.60%)

, GH

Guardant Health

$126.36 /

-0.65 (-0.51%)

, LLY

Eli Lilly

$231.73 /

-1.94 (-0.83%)

, IPSEY

Ipsen

$24.09 /

-0.115 (-0.48%)

, EXAS

Exact Sciences

$102.18 /

-2.46 (-2.35%)

, IDYA

Ideaya Biosciences

$25.87 /

-0.13 (-0.50%)

, GSK

GlaxoSmithKline

$38.92 /

-0.29 (-0.74%)

, RHHBY

Roche

$46.86 /

+0.11 (+0.24%)

, REGN

Regeneron

$647.54 /

-3.06 (-0.47%)

, PFE

Pfizer

$44.70 /

-0.07 (-0.16%)

, TAK

Takeda Pharmaceutical

$17.14 /

+0.14 (+0.82%)

, TMO

Thermo Fisher

$558.70 /

-4.135 (-0.73%)

, TCRR

TCR2 Therapeutics

$16.17 /

-0.05 (-0.31%)

, VERU

Veru

$8.70 /

-0.1 (-1.14%)

, VBLT

VBL Therapeutics

$2.30 /

+0.005 (+0.22%)

, VTRS

Viatris

$13.78 /

+0.05 (+0.36%)

, NVS

Novartis

$84.33 /

-0.735 (-0.86%)

ESMO 2021 Virtual…

ESMO 2021 Virtual Congress will be held on September 16-21. Webcast Link

ShowHide Related Items >><<
VTRS Viatris
$13.78 /

+0.05 (+0.36%)

VERU Veru
$8.70 /

-0.1 (-1.14%)

VBLT VBL Therapeutics
$2.30 /

+0.005 (+0.22%)

TMO Thermo Fisher
$558.70 /

-4.135 (-0.73%)

TCRR TCR2 Therapeutics
$16.17 /

-0.05 (-0.31%)

TAK Takeda Pharmaceutical
$17.14 /

+0.14 (+0.82%)

SYNH Syneos Health
$93.28 /

-0.43 (-0.46%)

RHHBY Roche
$46.86 /

+0.11 (+0.24%)

REGN Regeneron
$647.54 /

-3.06 (-0.47%)

PFE Pfizer
$44.70 /

-0.07 (-0.16%)

ORIC Oric Pharmaceuticals
$25.02 /

+0.22 (+0.89%)

NVS Novartis
$84.33 /

-0.735 (-0.86%)

LPTX Leap Therapeutics
$2.34 /

+0.39 (+20.00%)

LLY Eli Lilly
$231.73 /

-1.94 (-0.83%)

IPSEY Ipsen
$24.09 /

-0.115 (-0.48%)

IDYA Ideaya Biosciences
$25.87 /

-0.13 (-0.50%)

GSK GlaxoSmithKline
$38.92 /

-0.29 (-0.74%)

GMAB Genmab
$42.26 /

-0.57 (-1.33%)

GILD Gilead
$71.34 /

-0.43 (-0.60%)

GH Guardant Health
$126.36 /

-0.65 (-0.51%)

EXAS Exact Sciences
$102.18 /

-2.46 (-2.35%)

DCPH Deciphera
$30.40 /

-0.65 (-2.09%)

CALA Calithera Biosciences
$2.06 /

-0.03 (-1.44%)

BYSI BeyondSpring
$22.25 /

-0.73 (-3.18%)

BMY Bristol-Myers
$61.18 /

-0.82 (-1.32%)

BGNE BeiGene
$377.63 /

+3.31 (+0.88%)

AYLA Ayala Pharmaceuticals
$14.30 /

+0.28 (+2.00%)

ABBV AbbVie
$107.05 /

-0.74 (-0.69%)

ABBV AbbVie
$107.05 /

-0.74 (-0.69%)

09/14/21 Barclays
Regenxbio price target raised to $82 from $79 at Barclays
09/13/21 Chardan
Regenxbio pact with AbbVie accelerates RGX-314 'value capture,' says Chardan
09/08/21 JPMorgan
AbbVie offers 'best risk/reward story in the group,' says JPMorgan
09/07/21 Morgan Stanley
Morgan Stanley cuts Vertex Pharmaceuticals to Underweight amid AbbVie overhang
AYLA Ayala Pharmaceuticals
$14.30 /

+0.28 (+2.00%)

07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with Buy, $29 target at Ladenburg
07/13/21 Ladenburg
Ayala Pharmaceuticals initiated with a Buy at Ladenburg
12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
DCPH Deciphera
$30.40 /

-0.65 (-2.09%)

08/04/21 H.C. Wainwright
Deciphera price target lowered to $70 from $75 at H.C. Wainwright
05/05/21 Barclays
Deciphera price target lowered to $65 from $70 at Barclays
05/05/21 H.C. Wainwright
Deciphera price target lowered to $75 from $80 at H.C. Wainwright
05/05/21 Piper Sandler
Deciphera price target lowered to $60 from $75 at Piper Sandler
GMAB Genmab
$42.26 /

-0.57 (-1.33%)

09/16/21
Fly Intel: Top five analyst downgrades
09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Genmab to Underweight amid high investor expectations
LPTX Leap Therapeutics
$2.34 /

+0.39 (+20.00%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
ORIC Oric Pharmaceuticals
$25.02 /

+0.22 (+0.89%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
SYNH Syneos Health
$93.28 /

-0.43 (-0.46%)

08/04/21 Credit Suisse
Syneos Health assumed with an Outperform at Credit Suisse
07/13/21 Barclays
Syneos Health price target raised to $102 from $90 at Barclays
06/02/21 Truist
Syneos Health price target raised to $104 from $88 at Truist
04/30/21 Mizuho
Syneos Health price target raised to $90 from $82 at Mizuho
BGNE BeiGene
$377.63 /

+3.31 (+0.88%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
BMY Bristol-Myers
$61.18 /

-0.82 (-1.32%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BYSI BeyondSpring
$22.25 /

-0.73 (-3.18%)

09/08/21 Baird
BeyondSpring initiated with an Outperform at Baird
08/04/21 Evercore ISI
BeyondSpring price target raised to $95 from $30 at Evercore ISI
08/04/21 William Blair
BeyondSpring may have new standard of care in lung cancer, says William Blair
08/04/21 H.C. Wainwright
Wainwright upgrades BeyondSpring with $100 target on lung cancer data
CALA Calithera Biosciences
$2.06 /

-0.03 (-1.44%)

01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform at SVB Leerink
01/05/21 SVB Leerink
Calithera Biosciences downgraded to Market Perform from Outperform at SVB Leerink
01/05/21 Citi
Calithera Biosciences price target lowered to $5 from $10 at Citi
01/05/21 H.C. Wainwright
Calithera Biosciences price target lowered to $4 from $9.50 at H.C. Wainwright
GILD Gilead
$71.34 /

-0.43 (-0.60%)

07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GH Guardant Health
$126.36 /

-0.65 (-0.51%)

08/09/21 Canaccord
Guardant Health price target lowered to $180 from $195 at Canaccord
06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
LLY Eli Lilly
$231.73 /

-1.94 (-0.83%)

09/02/21 SVB Leerink
AbbVie price target lowered to $142 from $148 at SVB Leerink
08/30/21 Cowen
Eli Lilly price target raised to $300 from $250 at Cowen
08/30/21 Citi
Lexicon price target raised to $20 from $13 at Citi
IPSEY Ipsen
$24.09 /

-0.115 (-0.48%)

08/16/21 Morgan Stanley
Ipsen price target lowered to EUR 88 from EUR 92 at Morgan Stanley
08/03/21 Morgan Stanley
Ipsen price target raised to EUR 92 from EUR 85 at Morgan Stanley
08/02/21 Societe Generale
Ipsen price target raised to EUR 101 from EUR 90 at Societe Generale
07/30/21 Credit Suisse
Ipsen price target raised to EUR 90 from EUR 75 at Credit Suisse
EXAS Exact Sciences
$102.18 /

-2.46 (-2.35%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/15/21 Canaccord
Exact Sciences progress in MRD space a positive, says Canaccord
09/01/21 Baird
UnitedHealth update to CRC screening coverage not a surprise, says Baird
IDYA Ideaya Biosciences
$25.87 /

-0.13 (-0.50%)

06/03/21 Baird
Ideaya Biosciences assumed with an Outperform at Baird
04/22/21 Roth Capital
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
04/19/21 H.C. Wainwright
Ideaya Biosciences price target raised to $35 from $29 at H.C. Wainwright
04/16/21 Roth Capital
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
GSK GlaxoSmithKline
$38.92 /

-0.29 (-0.74%)

08/26/21 UBS
GlaxoSmithKline price target raised to 1,540 GBp from 1,485 GBp at UBS
08/20/21 JPMorgan
GlaxoSmithKline price target raised to 1,500 GBp from 1,300 GBp at JPMorgan
08/19/21 Berenberg
GlaxoSmithKline price target raised to 1,625 GBp from 1,570 GBp at Berenberg
RHHBY Roche
$46.86 /

+0.11 (+0.24%)

09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
REGN Regeneron
$647.54 /

-3.06 (-0.47%)

09/15/21 Cantor Fitzgerald
Regeneron price target raised to $700 from $670 at Cantor Fitzgerald
09/15/21 H.C. Wainwright
Regeneron price target raised to $831 from $787 at H.C. Wainwright
09/15/21 Piper Sandler
Regeneron price target raised to $690 from $675 at Piper Sandler
09/09/21
Fly Intel: Top five analyst initiations
PFE Pfizer
$44.70 /

-0.07 (-0.16%)

09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/13/21 JPMorgan
Pfizer price target raised to $42 from $40 at JPMorgan
TAK Takeda Pharmaceutical
$17.14 /

+0.14 (+0.82%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
TMO Thermo Fisher
$558.70 /

-4.135 (-0.73%)

08/04/21 Credit Suisse
Thermo Fisher assumed with an Outperform at Credit Suisse
08/04/21 Argus
Thermo Fisher price target raised to $600 from $530 at Argus
07/29/21 Cowen
Thermo Fisher price target raised to $560 from $525 at Cowen
07/29/21 BTIG
Thermo Fisher price target raised to $610 from $590 at BTIG
TCRR TCR2 Therapeutics
$16.17 /

-0.05 (-0.31%)

08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
VERU Veru
$8.70 /

-0.1 (-1.14%)

04/13/21 Jefferies
Veru initiated with a Buy at Jefferies
02/11/21 Oppenheimer
Veru price target raised to $24 from $19 at Oppenheimer
02/11/21 H.C. Wainwright
Veru price target raised to $22 from $17 at H.C. Wainwright
02/09/21 H.C. Wainwright
Veru price target raised to $17 from $12 at H.C. Wainwright
VBLT VBL Therapeutics
$2.30 /

+0.005 (+0.22%)

08/30/21 Roth Capital
Roth bullish on VBL Therapeutics as U.S. Phase 3 OVAL trial enrollment resumes
06/15/21 Roth Capital
Roth does not see material change to VBL readout timelines
06/03/21 Roth Capital
Roth Capital ups VBL Therapeutics target to $7 on OVAL primary endpoint update
05/18/21 Guggenheim
VBL Therapeutics initiated with a Buy at Guggenheim
VTRS Viatris
$13.78 /

+0.05 (+0.36%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
NVS Novartis
$84.33 /

-0.735 (-0.86%)

09/07/21 Wedbush
Wedbush downgrades Xoma to Neutral, cuts target to $22
07/28/21 JPMorgan
Novartis price target raised to CHF 84 from CHF 80 at JPMorgan
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
VTRS Viatris
$13.78 /

+0.05 (+0.36%)

VERU Veru
$8.70 /

-0.1 (-1.14%)

VBLT VBL Therapeutics
$2.30 /

+0.005 (+0.22%)

TMO Thermo Fisher
$558.70 /

-4.135 (-0.73%)

TCRR TCR2 Therapeutics
$16.17 /

-0.05 (-0.31%)

TAK Takeda Pharmaceutical
$17.14 /

+0.14 (+0.82%)

SYNH Syneos Health
$93.28 /

-0.43 (-0.46%)

RHHBY Roche
$46.86 /

+0.11 (+0.24%)

REGN Regeneron
$647.54 /

-3.06 (-0.47%)

PFE Pfizer
$44.70 /

-0.07 (-0.16%)

ORIC Oric Pharmaceuticals
$25.02 /

+0.22 (+0.89%)

NVS Novartis
$84.33 /

-0.735 (-0.86%)

LPTX Leap Therapeutics
$2.34 /

+0.39 (+20.00%)

LLY Eli Lilly
$231.73 /

-1.94 (-0.83%)

IDYA Ideaya Biosciences
$25.87 /

-0.13 (-0.50%)

GSK GlaxoSmithKline
$38.92 /

-0.29 (-0.74%)

GILD Gilead
$71.34 /

-0.43 (-0.60%)

GH Guardant Health
$126.36 /

-0.65 (-0.51%)

EXAS Exact Sciences
$102.18 /

-2.46 (-2.35%)

DCPH Deciphera
$30.40 /

-0.65 (-2.09%)

CALA Calithera Biosciences
$2.06 /

-0.03 (-1.44%)

BYSI BeyondSpring
$22.25 /

-0.73 (-3.18%)

BMY Bristol-Myers
$61.18 /

-0.82 (-1.32%)

BGNE BeiGene
$377.63 /

+3.31 (+0.88%)

AYLA Ayala Pharmaceuticals
$14.30 /

+0.28 (+2.00%)

ABBV AbbVie
$107.05 /

-0.74 (-0.69%)

  • 08
    Jul
  • 03
    Jun
  • 04
    May
  • 09
    Apr
  • 01
    Mar
  • 18
    Feb
  • 20
    Jan
  • 02
    Dec
  • 02
    Dec
  • 19
    Nov
  • 13
    Nov
  • 07
    Oct
TMO Thermo Fisher
$558.70 /

-4.135 (-0.73%)

TAK Takeda Pharmaceutical
$17.14 /

+0.14 (+0.82%)

SYNH Syneos Health
$93.28 /

-0.43 (-0.46%)

RHHBY Roche
$46.86 /

+0.11 (+0.24%)

REGN Regeneron
$647.54 /

-3.06 (-0.47%)

PFE Pfizer
$44.70 /

-0.07 (-0.16%)

NVS Novartis
$84.33 /

-0.735 (-0.86%)

LLY Eli Lilly
$231.73 /

-1.94 (-0.83%)

GSK GlaxoSmithKline
$38.92 /

-0.29 (-0.74%)

GILD Gilead
$71.34 /

-0.43 (-0.60%)

EXAS Exact Sciences
$102.18 /

-2.46 (-2.35%)

BMY Bristol-Myers
$61.18 /

-0.82 (-1.32%)

BGNE BeiGene
$377.63 /

+3.31 (+0.88%)

ABBV AbbVie
$107.05 /

-0.74 (-0.69%)

VERU Veru
$8.70 /

-0.1 (-1.14%)

TMO Thermo Fisher
$558.70 /

-4.135 (-0.73%)

TAK Takeda Pharmaceutical
$17.14 /

+0.14 (+0.82%)

RHHBY Roche
$46.86 /

+0.11 (+0.24%)

REGN Regeneron
$647.54 /

-3.06 (-0.47%)

PFE Pfizer
$44.70 /

-0.07 (-0.16%)

ORIC Oric Pharmaceuticals
$25.02 /

+0.22 (+0.89%)

NVS Novartis
$84.33 /

-0.735 (-0.86%)

LPTX Leap Therapeutics
$2.34 /

+0.39 (+20.00%)

LLY Eli Lilly
$231.73 /

-1.94 (-0.83%)

IDYA Ideaya Biosciences
$25.87 /

-0.13 (-0.50%)

GSK GlaxoSmithKline
$38.92 /

-0.29 (-0.74%)

GMAB Genmab
$42.26 /

-0.57 (-1.33%)

GILD Gilead
$71.34 /

-0.43 (-0.60%)

GH Guardant Health
$126.36 /

-0.65 (-0.51%)

EXAS Exact Sciences
$102.18 /

-2.46 (-2.35%)

BYSI BeyondSpring
$22.25 /

-0.73 (-3.18%)

BMY Bristol-Myers
$61.18 /

-0.82 (-1.32%)

ABBV AbbVie
$107.05 /

-0.74 (-0.69%)

VTRS Viatris
$13.78 /

+0.05 (+0.36%)

VERU Veru
$8.70 /

-0.1 (-1.14%)

TAK Takeda Pharmaceutical
$17.14 /

+0.14 (+0.82%)

REGN Regeneron
$647.54 /

-3.06 (-0.47%)

PFE Pfizer
$44.70 /

-0.07 (-0.16%)

LLY Eli Lilly
$231.73 /

-1.94 (-0.83%)

GSK GlaxoSmithKline
$38.92 /

-0.29 (-0.74%)

GILD Gilead
$71.34 /

-0.43 (-0.60%)

BYSI BeyondSpring
$22.25 /

-0.73 (-3.18%)

BMY Bristol-Myers
$61.18 /

-0.82 (-1.32%)

ABBV AbbVie
$107.05 /

-0.74 (-0.69%)

Recommendations
Fortinet price target raised to $335 from $300 at BMO Capital » 08:54
09/16/21
09/16
08:54
09/16/21
08:54
FTNT

Fortinet

$301.51 /

+0.86 (+0.29%)

BMO Capital analyst Keith…

BMO Capital analyst Keith Bachman raised the firm's price target on Fortinet to $335 from $300 but keeps a Market Perform rating on the shares after the company's recent customer event in Napa. Fortinet has a long runway for growth as migration of more workloads to the cloud also increases security complexity and requirements, but the stock's multiple has limited upside potential beyond what is captured in his new target price, the analyst tells investors in a research note.

ShowHide Related Items >><<
FTNT Fortinet
$301.51 /

+0.86 (+0.29%)

FTNT Fortinet
$301.51 /

+0.86 (+0.29%)

09/15/21 Mizuho
Fortinet price target raised to $290 from $260 at Mizuho
08/13/21 BTIG
Fortinet price target raised to $345 from $305 at BTIG
07/30/21 BMO Capital
Fortinet price target raised to $300 from $275 at BMO Capital
07/30/21 Cowen
Fortinet price target raised to $335 from $305 at Cowen
FTNT Fortinet
$301.51 /

+0.86 (+0.29%)

FTNT Fortinet
$301.51 /

+0.86 (+0.29%)

FTNT Fortinet
$301.51 /

+0.86 (+0.29%)

FTNT Fortinet
$301.51 /

+0.86 (+0.29%)

Hot Stocks
Gilead says data evaluating Trodelvy in patients with TNBC show improvement » 07:08
09/16/21
09/16
07:08
09/16/21
07:08
GILD

Gilead

$71.79 /

+1.32 (+1.87%)

Gilead Sciences announced…

Gilead Sciences announced new data from the Phase 3 ASCENT study evaluating Trodelvy, sacituzumab govitecan-hziy, in patients with relapsed or refractory metastatic triple-negative breast cancer TNBC who received two or more prior systemic therapies, at least one of them for metastatic disease. In a retrospective subgroup analysis, Trodelvy improved progression-free survival PFS, overall survival OS and objective response rate ORR compared with chemotherapy chosen by the patients' physicians in patients who were not initially diagnosed with TNBC. The results were presented at the European Society of Medical Oncology Congress 2021 from September 16-21, 202 "In the metastatic stage of breast cancer, it is not uncommon for people to change from one subtype to another," said Javier Cortes, MD, Head of the International Breast Cancer Center (IBCC), Madrid and Barcelona, Spain. "Roughly one-third of patients with TNBC in the ASCENT study were not originally diagnosed with TNBC, and they still experienced a survival benefit with Trodelvy compared with chemotherapy. For treating physicians, this reinforces Trodelvy's efficacy in more complex patients." "Trodelvy is already transforming outcomes for patients with second-line or later metastatic TNBC," said Bill Grossman, MD, PhD, Senior Vice President, Oncology Clinical Research, Gilead Sciences. "Gilead is committed to continued research that further defines the clinical profile of Trodelvy. As such, we are pleased that this sub-analysis in patients not initially diagnosed with TNBC demonstrated similarly strong overall survival, progression-free survival and response rates as were observed in the overall ASCENT study population."

ShowHide Related Items >><<
GILD Gilead
$71.79 /

+1.32 (+1.87%)

GILD Gilead
$71.79 /

+1.32 (+1.87%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GILD Gilead
$71.79 /

+1.32 (+1.87%)

GILD Gilead
$71.79 /

+1.32 (+1.87%)

GILD Gilead
$71.79 /

+1.32 (+1.87%)

GILD Gilead
$71.79 /

+1.32 (+1.87%)

Hot Stocks
Gilead announces new ASCENT study data » 07:05
09/16/21
09/16
07:05
09/16/21
07:05
GILD

Gilead

$71.79 /

+1.32 (+1.87%)

Gilead announced new data…

Gilead announced new data from the Phase 3 ASCENT study evaluating Trodelvy in patients with relapsed or refractory metastatic triple-negative breast cancer, or TNBC, who received two or more prior systemic therapies, at least one of them for metastatic disease. In a retrospective subgroup analysis, Trodelvy improved progression-free survival, or PFS, overall survival, or OS, and objective response rate, or ORR, compared with chemotherapy chosen by the patients' physicians in patients who were not initially diagnosed with TNBC. The results were presented at the European Society of Medical Oncology Congress from September 16-21. This analysis included 146 chemotherapy-eligible brain metastasis-negative patients with an original breast cancer diagnosis that was not TNBC, of which 70 received Trodelvy and 76 received physician's choice of chemotherapy. Among these patients, Trodelvy improved median PFS compared with chemotherapy, median OS and ORR. Outcomes were similar to those of the overall ASCENT trial population. The safety profile of Trodelvy in this subgroup was consistent with prior reports from the ASCENT study. Key treatment-related grade greater than or equal to three adverse events for Trodelvy compared to chemotherapy were neutropenia, leukopenia, anemia and diarrhea. There were no treatment-related deaths with Trodelvy.

ShowHide Related Items >><<
GILD Gilead
$71.79 /

+1.32 (+1.87%)

GILD Gilead
$71.79 /

+1.32 (+1.87%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
GILD Gilead
$71.79 /

+1.32 (+1.87%)

GILD Gilead
$71.79 /

+1.32 (+1.87%)

GILD Gilead
$71.79 /

+1.32 (+1.87%)

GILD Gilead
$71.79 /

+1.32 (+1.87%)

Periodicals
FTC study shows hundreds of tech giant deals went unchecked, Bloomberg reports » 06:04
09/16/21
09/16
06:04
09/16/21
06:04
GOOG

Alphabet

$2,904.02 /

+34.46 (+1.20%)

, GOOGL

Alphabet Class A

$2,888.98 /

+39.79 (+1.40%)

, AAPL

Apple

$149.10 /

+0.92 (+0.62%)

, AMZN

Amazon.com

$3,475.74 /

+25.67 (+0.74%)

, FB

Facebook

$373.92 /

-2.68 (-0.71%)

, MSFT

Microsoft

$304.85 /

+4.96 (+1.65%)

An FTC study says…

An FTC study says Alphabet (GOOGL), Amazon (AMZN), Apple (AAPL), Facebook (FB), and Microsoft (MSFT) made 819 unreported acquisition deals of over $1M, including for patents and acquihires, from 2010 to 2019, Bloomberg's David McLaughlin reports. The data on acquisitions show that antitrust enforcers must be more aggressive in making sure companies aren't taking advantage of "loopholes" to avoid reporting deals to regulators, FTC Chair Lina Khan says, commenting that "This study highlights the systemic nature of their acquisition strategy." Reference Link

ShowHide Related Items >><<
MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

GOOG Alphabet
$2,904.02 /

+34.46 (+1.20%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

AAPL Apple
$149.10 /

+0.92 (+0.62%)

GOOG Alphabet
$2,904.02 /

+34.46 (+1.20%)

09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Alphabet Class A initiated with a Buy at Goldman Sachs
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
09/01/21 Canaccord
Anaplan results underscores its value proposition, says Canaccord
GOOGL Alphabet Class A
$2,888.98 /

+39.79 (+1.40%)

09/01/21 Rosenblatt
Facebook downgraded to Neutral from Buy at Rosenblatt
AAPL Apple
$149.10 /

+0.92 (+0.62%)

09/15/21 Oppenheimer
Apple's iPhone 13 likely to attract upgraders, says Oppenheimer
09/15/21 Deutsche Bank
Apple iPhone changes 'more incremental than transformative,' says Deutsche Bank
09/15/21 Morgan Stanley
Improved iPhone affordability raises Morgan Stanley confidence in Apple growth
09/15/21 Citi
Apple's new iPhone, Watch features largely as anticipated, says Citi
AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

09/14/21 Evercore ISI
Amazon price target raised to $4,700 from $4,200 at Evercore ISI
09/13/21 Goldman Sachs
Amazon.com initiated with a Buy at Goldman Sachs
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
FB Facebook
$373.92 /

-2.68 (-0.71%)

09/13/21 Goldman Sachs
Facebook initiated with a Buy at Goldman Sachs
09/09/21 HSBC
Facebook price target raised to $300 from $275 at HSBC
09/01/21
Fly Intel: Top five analyst downgrades
MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

09/14/21 Morgan Stanley
Microsoft price target raised to $331 from $305 at Morgan Stanley
09/08/21 Jefferies
Microsoft price target raised to $345 from $335 at Jefferies
09/06/21 Jefferies
Oracle price target raised to $95 from $80 at Jefferies
08/31/21 UBS
Zoom Video price target lowered to $315 from $345 at UBS
MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

GOOG Alphabet
$2,904.02 /

+34.46 (+1.20%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

AAPL Apple
$149.10 /

+0.92 (+0.62%)

MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

GOOGL Alphabet Class A
$2,888.98 /

+39.79 (+1.40%)

GOOG Alphabet
$2,904.02 /

+34.46 (+1.20%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

AAPL Apple
$149.10 /

+0.92 (+0.62%)

MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

GOOGL Alphabet Class A
$2,888.98 /

+39.79 (+1.40%)

GOOG Alphabet
$2,904.02 /

+34.46 (+1.20%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

AAPL Apple
$149.10 /

+0.92 (+0.62%)

MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

GOOGL Alphabet Class A
$2,888.98 /

+39.79 (+1.40%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

AAPL Apple
$149.10 /

+0.92 (+0.62%)

AAPL Apple
$149.10 /

+0.92 (+0.62%)

Wednesday
On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:30
09/15/21
09/15
16:30
09/15/21
16:30
KSU

Kansas City Southern

$281.68 /

+1.495 (+0.53%)

, CNI

Canadian National

$117.29 /

+2.35 (+2.04%)

, CP

Canadian Pacific

$68.77 /

+0.62 (+0.91%)

, MSFT

Microsoft

$304.85 /

+4.96 (+1.65%)

, F

Ford

$13.21 /

+0.35 (+2.72%)

, WMT

Walmart

$144.53 /

+0.28 (+0.19%)

, GS

Goldman Sachs

$401.95 /

-2.12 (-0.52%)

, GSKY

GreenSky

$11.87 /

+4.1 (+52.77%)

, WKHS

Workhorse Group

$8.22 /

-0.23 (-2.72%)

, CVX

Chevron

$98.24 /

+2.07 (+2.15%)

, SE

Sea Limited

$337.51 /

+4.18 (+1.25%)

, LCID

Lucid Group

$19.89 /

+0.93 (+4.91%)

, LVS

Las Vegas Sands

$38.07 /

-0.64 (-1.65%)

, MGM

MGM Resorts

$40.39 /

-1.02 (-2.46%)

, WYNN

Wynn Resorts

$86.44 /

-5.83 (-6.32%)

, MLCO

Melco Resorts & Entertainment

$10.29 /

-1.65 (-13.82%)

, SOFI

SoFi Technologies

$15.44 /

+0.97 (+6.70%)

, FB

Facebook

$373.92 /

-2.68 (-0.71%)

, PFE

Pfizer

$44.77 /

+0.07 (+0.16%)

, BNTX

BioNTech

$355.75 /

+21.05 (+6.29%)

, CTXS

Citrix

$112.49 /

+2.87 (+2.62%)

, AMZN

Amazon.com

$3,475.74 /

+25.67 (+0.74%)

, TROW

T. Rowe Price

$214.94 /

+2.02 (+0.95%)

, AMPE

Ampio

$1.71 /

+0.255 (+17.53%)

, SM

SM Energy

$23.02 /

+2.72 (+13.40%)

, TBPH

Theravance Biopharma

$6.75 /

-1.28 (-15.94%)

, EA

Electronic Arts

$137.04 /

-8.37 (-5.76%)

, DNMR

Danimer Scientific

$14.72 /

-2.53 (-14.67%)

, WEBR

Weber

$14.92 /

+0.98 (+7.03%)

, SKIL

Skillsoft

$10.35 /

+0.39 (+3.92%)

, JKS

JinkoSolar

$48.68 /

+1.94 (+4.15%)

, YUMC

Yum China

$57.59 /

-3.62 (-5.91%)

, STLD

Steel Dynamics

$64.99 /

+3.03 (+4.89%)

Get caught up quickly on…

ShowHide Related Items >><<
YUMC Yum China
$57.59 /

-3.62 (-5.91%)

WYNN Wynn Resorts
$86.44 /

-5.83 (-6.32%)

WMT Walmart
$144.53 /

+0.28 (+0.19%)

WKHS Workhorse Group
$8.22 /

-0.23 (-2.72%)

WEBR Weber
$14.92 /

+0.98 (+7.03%)

TROW T. Rowe Price
$214.94 /

+2.02 (+0.95%)

TBPH Theravance Biopharma
$6.75 /

-1.28 (-15.94%)

STLD Steel Dynamics
$64.99 /

+3.03 (+4.89%)

SOFI SoFi Technologies
$15.44 /

+0.97 (+6.70%)

SM SM Energy
$23.02 /

+2.72 (+13.40%)

SKIL Skillsoft
$10.35 /

+0.39 (+3.92%)

SE Sea Limited
$337.51 /

+4.18 (+1.25%)

PFE Pfizer
$44.77 /

+0.07 (+0.16%)

MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

MLCO Melco Resorts & Entertainment
$10.29 /

-1.65 (-13.82%)

MGM MGM Resorts
$40.39 /

-1.02 (-2.46%)

LVS Las Vegas Sands
$38.07 /

-0.64 (-1.65%)

LCID Lucid Group
$19.89 /

+0.93 (+4.91%)

KSU Kansas City Southern
$281.68 /

+1.495 (+0.53%)

JKS JinkoSolar
$48.68 /

+1.94 (+4.15%)

GSKY GreenSky
$11.87 /

+4.1 (+52.77%)

GS Goldman Sachs
$401.95 /

-2.12 (-0.52%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

F Ford
$13.21 /

+0.35 (+2.72%)

EA Electronic Arts
$137.04 /

-8.37 (-5.76%)

DNMR Danimer Scientific
$14.72 /

-2.53 (-14.67%)

CVX Chevron
$98.24 /

+2.07 (+2.15%)

CTXS Citrix
$112.49 /

+2.87 (+2.62%)

CNI Canadian National
$117.29 /

+2.35 (+2.04%)

BNTX BioNTech
$355.75 /

+21.05 (+6.29%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

AMPE Ampio
$1.71 /

+0.255 (+17.53%)

KSU Kansas City Southern
$281.68 /

+1.495 (+0.53%)

09/15/21
Fly Intel: Top five analyst downgrades
09/15/21 Wolfe Research
Kansas City Southern downgraded to Peer Perform from Outperform at Wolfe Research
09/14/21 TD Securities
Canadian National downgraded to Hold from Buy at TD Securities
09/08/21 Deutsche Bank
Canadian National shares not 'overly compelling' after rally, says Deutsche Bank
CNI Canadian National
$117.29 /

+2.35 (+2.04%)

09/07/21 CIBC
Canadian National price target raised to C$170 from C$158 at CIBC
CP Canadian Pacific
$68.77 /

+0.62 (+0.91%)

09/01/21 Loop Capital
Canadian National, Kansas City Southern cut to Hold at Loop Capital
08/12/21 Argus
Canadian Pacific downgraded to Hold from Buy at Argus
08/12/21 Argus
Canadian Pacific downgraded to Hold from Buy at Argus
MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

09/14/21 Morgan Stanley
Microsoft price target raised to $331 from $305 at Morgan Stanley
09/08/21 Jefferies
Microsoft price target raised to $345 from $335 at Jefferies
09/06/21 Jefferies
Oracle price target raised to $95 from $80 at Jefferies
08/31/21 UBS
Zoom Video price target lowered to $315 from $345 at UBS
F Ford
$13.21 /

+0.35 (+2.72%)

09/08/21 Benchmark
Worst of chip shortage could be over for Ford, says Benchmark
07/16/21 BofA
Ford price target raised to $18 from $17 at BofA
06/29/21 UBS
Ford price target raised to $16 from $13 at UBS
06/22/21 Barclays
Ford price target raised to $17 from $15 at Barclays
WMT Walmart
$144.53 /

+0.28 (+0.19%)

08/30/21 Credit Suisse
Amazon deal could add 35%-40% to Affirm contribution profit, says Credit Suisse
08/27/21 Tigress Financial
Walmart valuation limits outperformance potential, says Tigress Financial
08/18/21 Cowen
Walmart price target raised to $175 from $170 at Cowen
08/18/21 DA Davidson
Walmart's Q2 results should support stock gains, says DA Davidson
GS Goldman Sachs
$401.95 /

-2.12 (-0.52%)

07/14/21 Oppenheimer
Goldman Sachs price target raised to $540 from $493 at Oppenheimer
07/14/21 Credit Suisse
Goldman Sachs price target raised to $425 from $420 at Credit Suisse
07/14/21 Mizuho
Affirm selloff on Apple competition fears overblown, says Mizuho
07/14/21 Piper Sandler
Goldman Sachs price target raised to $435 from $420 at Piper Sandler
GSKY GreenSky
$11.87 /

+4.1 (+52.77%)

08/17/21 JPMorgan
GreenSky assumed with an Overweight at JPMorgan
08/02/21 Stephens
GreenSky upgraded to Equal Weight on guidance upside at Stephens
08/02/21 Stephens
GreenSky upgraded to Equal Weight from Underweight at Stephens
07/29/21 Citi
GreenSky upgraded to Neutral from Sell at Citi
WKHS Workhorse Group
$8.22 /

-0.23 (-2.72%)

08/10/21 DA Davidson
Workhorse Group initiated with a Neutral at DA Davidson
08/10/21 B. Riley
Workhorse Group price target lowered to $14 from $16 at B. Riley
08/09/21 BTIG
BTIG lowers Workhorse Group target to $18 following Q2 results
07/29/21 B. Riley
Workhorse Group's new CEO Dauch a 'nice fit,' says B. Riley
CVX Chevron
$98.24 /

+2.07 (+2.15%)

09/15/21 Citi
Chevron energy transition update as expected, says Citi
09/15/21 JPMorgan
Chevron downgraded to Neutral on higher spending at JPMorgan
09/15/21 JPMorgan
Chevron downgraded to Neutral from Overweight at JPMorgan
SE Sea Limited
$337.51 /

+4.18 (+1.25%)

09/15/21
Fly Intel: Top five analyst upgrades
09/15/21 Stifel
Stifel upgrades Sea Limited to Buy with $400 price target
09/15/21 Stifel
Sea Limited upgraded to Buy from Hold at Stifel
08/19/21
Fly Intel: Top five analyst downgrades
LCID Lucid Group
$19.89 /

+0.93 (+4.91%)

09/15/21 BofA
BofA calls Lucid the 'Tesla/Ferrari of new EV automakers,' starts at Buy
09/15/21 BofA
Lucid Group initiated with a Buy at BofA
09/13/21 Morgan Stanley
Lucid Group initiated with an Underweight at Morgan Stanley
09/09/21
Fly Intel: Top five analyst initiations
LVS Las Vegas Sands
$38.07 /

-0.64 (-1.65%)

09/16/21 JPMorgan
JPMorgan downgrades Las Vegas Sands on Macau uncertainty
09/16/21 JPMorgan
Las Vegas Sands downgraded to Neutral from Overweight at JPMorgan
09/14/21 Wells Fargo
Las Vegas Sands initiated with an Equal Weight at Wells Fargo
09/14/21 Credit Suisse
Macau consultation has negative read for gaming sector, says Credit Suisse
MGM MGM Resorts
$40.39 /

-1.02 (-2.46%)

09/14/21 Wells Fargo
MGM Resorts initiated with an Overweight at Wells Fargo
09/13/21
Fly Intel: Top five analyst upgrades
09/13/21 Bernstein
MGM Resorts upgraded to Outperform from Market Perform at Bernstein
WYNN Wynn Resorts
$86.44 /

-5.83 (-6.32%)

09/16/21 JPMorgan
Wynn Resorts downgraded on Macau uncertainty at JPMorgan
09/16/21 JPMorgan
Wynn Resorts downgraded to Neutral from Overweight at JPMorgan
09/14/21 Wells Fargo
Wynn Resorts initiated with an Equal Weight at Wells Fargo
MLCO Melco Resorts & Entertainment
$10.29 /

-1.65 (-13.82%)

09/16/21 JPMorgan
JPMorgan downgrades Melco Resorts to Neutral on Macau uncertainty
09/16/21 JPMorgan
Melco Resorts downgraded to Neutral from Overweight at JPMorgan
07/28/21 HSBC
HSBC upgrades 'oversold' Melco Resorts to Buy after Q2 EBITDA beat
SOFI SoFi Technologies
$15.44 /

+0.97 (+6.70%)

09/14/21 Mizuho
Mizuho starts SoFi with Buy amid 'powerful transition' to 'neo-bank'
09/14/21 Mizuho
SoFi Technologies initiated with a Buy at Mizuho
09/09/21 Credit Suisse
SoFi Technologies initiated with a Neutral at Credit Suisse
FB Facebook
$373.92 /

-2.68 (-0.71%)

09/13/21 Goldman Sachs
Facebook initiated with a Buy at Goldman Sachs
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
09/09/21 HSBC
Facebook price target raised to $300 from $275 at HSBC
09/01/21
Fly Intel: Top five analyst downgrades
PFE Pfizer
$44.77 /

+0.07 (+0.16%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/13/21 JPMorgan
Pfizer price target raised to $42 from $40 at JPMorgan
BNTX BioNTech
$355.75 /

+21.05 (+6.29%)

08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
08/20/21 Canaccord
BioNTech price target raised to $450 from $240 at Canaccord
08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/11/21 H.C. Wainwright
BioNTech price target raised to $330 from $194 at H.C. Wainwright
CTXS Citrix
$112.49 /

+2.87 (+2.62%)

07/30/21 MKM Partners
Upwork price target raised to $65 from $58 at MKM Partners
07/30/21 RBC Capital
Citrix price target lowered to $110 from $150 at RBC Capital
07/30/21 Jefferies
Citrix price target lowered to $120 from $175 at Jefferies
04/21/21
Fly Intel: Top five analyst upgrades
AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

09/14/21 Evercore ISI
Amazon price target raised to $4,700 from $4,200 at Evercore ISI
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Goldman Sachs
Amazon.com initiated with a Buy at Goldman Sachs
09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
TROW T. Rowe Price
$214.94 /

+2.02 (+0.95%)

07/12/21 Deutsche Bank
T. Rowe Price price target raised to $185 from $171 at Deutsche Bank
07/12/21 Citi
T. Rowe Price price target raised to $145 from $137 at Citi
07/08/21 UBS
T. Rowe Price price target raised to $200 from $183 at UBS
06/15/21 Citi
T. Rowe Price still expensive despite special dividend, says Citi
AMPE Ampio
$1.71 /

+0.255 (+17.53%)

SM SM Energy
$23.02 /

+2.72 (+13.40%)

09/15/21 JPMorgan
SM Energy upgraded to Overweight on 'robust' cash flow at JPMorgan
09/15/21 JPMorgan
SM Energy upgraded to Overweight from Neutral at JPMorgan
07/07/21 Wells Fargo
SM Energy price target raised to $30 from $25 at Wells Fargo
06/24/21 Stifel
SM Energy price target raised to $39 from $19 at Stifel
TBPH Theravance Biopharma
$6.75 /

-1.28 (-15.94%)

09/16/21 Baird
Theravance Biopharma price target lowered to $7 from $10 at Baird
09/16/21 H.C. Wainwright
Theravance price target lowered to $8 from $21 at H.C. Wainwright
09/15/21 Cowen
Theravance Biopharma price target lowered to $8 from $14 at Cowen
09/15/21 Needham
Theravance Biopharma downgraded to Hold from Buy at Needham
EA Electronic Arts
$137.04 /

-8.37 (-5.76%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Raymond James
Delay of EA's Battlefield 2042 likely a 'mild negative,' says Raymond James
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
DNMR Danimer Scientific
$14.72 /

-2.53 (-14.67%)

02/09/21 Jefferies
Danimer Scientific price target raised to $66 from $49 at Jefferies
01/06/21 Jefferies
Danimer Scientific initiated with a Buy at Jefferies
WEBR Weber
$14.92 /

+0.98 (+7.03%)

08/30/21
Fly Intel: Top five analyst initiations
08/30/21 BofA
BofA starts 'iconic brand' Weber at Buy
08/30/21 JPMorgan
Weber initiated with an Overweight at JPMorgan
08/30/21 Wells Fargo
Weber initiated with an Equal Weight at Wells Fargo
SKIL Skillsoft
$10.35 /

+0.39 (+3.92%)

09/15/21 Barclays
Skillsoft price target raised to $13 from $12 at Barclays
09/15/21 Piper Sandler
Skillsoft price target raised to $12 from $11 at Piper Sandler
08/16/21 Oppenheimer
Skillsoft initiated with a Perform at Oppenheimer
08/03/21 Barclays
Skillsoft initiated with an Overweight at Barclays
JKS JinkoSolar
$48.68 /

+1.94 (+4.15%)

08/13/21 GLJ Research
JinkoSolar shipment into U.S. stopped by customs, says GLJ Research
07/02/21 Goldman Sachs
JinkoSolar price target raised to $27 from $25 at Goldman Sachs
06/30/21 Roth Capital
JinkoSolar price target raised to $58 from $39 at Roth Capital
04/16/21 UBS
JinkoSolar upgraded to Neutral from Sell at UBS
YUMC Yum China
$57.59 /

-3.62 (-5.91%)

09/15/21 Macquarie
Macquarie downgrades Yum China to sell on 'bumpy' sales recovery
09/15/21 Macquarie
Yum China downgraded to Underperform from Neutral at Macquarie
07/07/21 Goldman Sachs
Yum China price target raised to $77 from $74 at Goldman Sachs
04/29/21 RBC Capital
Yum China price target raised to $123 from $112 at RBC Capital
STLD Steel Dynamics
$64.99 /

+3.03 (+4.89%)

09/15/21 Deutsche Bank
Steel Dynamics price target raised to $98 from $72 at Deutsche Bank
08/23/21 Seaport Global
Steel Dynamics initiated with a Buy at Seaport Global
07/07/21 Credit Suisse
Steel demand booming in the U.S., says Credit Suisse
07/01/21 Deutsche Bank
Steel Dynamics price target raised to $72 from $68 at Deutsche Bank
YUMC Yum China
$57.59 /

-3.62 (-5.91%)

WYNN Wynn Resorts
$86.44 /

-5.83 (-6.32%)

WMT Walmart
$144.53 /

+0.28 (+0.19%)

WKHS Workhorse Group
$8.22 /

-0.23 (-2.72%)

WEBR Weber
$14.92 /

+0.98 (+7.03%)

TROW T. Rowe Price
$214.94 /

+2.02 (+0.95%)

TBPH Theravance Biopharma
$6.75 /

-1.28 (-15.94%)

STLD Steel Dynamics
$64.99 /

+3.03 (+4.89%)

SOFI SoFi Technologies
$15.44 /

+0.97 (+6.70%)

SM SM Energy
$23.02 /

+2.72 (+13.40%)

SKIL Skillsoft
$10.35 /

+0.39 (+3.92%)

SE Sea Limited
$337.51 /

+4.18 (+1.25%)

PFE Pfizer
$44.77 /

+0.07 (+0.16%)

MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

MLCO Melco Resorts & Entertainment
$10.29 /

-1.65 (-13.82%)

MGM MGM Resorts
$40.39 /

-1.02 (-2.46%)

LVS Las Vegas Sands
$38.07 /

-0.64 (-1.65%)

KSU Kansas City Southern
$281.68 /

+1.495 (+0.53%)

JKS JinkoSolar
$48.68 /

+1.94 (+4.15%)

GSKY GreenSky
$11.87 /

+4.1 (+52.77%)

GS Goldman Sachs
$401.95 /

-2.12 (-0.52%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

F Ford
$13.21 /

+0.35 (+2.72%)

EA Electronic Arts
$137.04 /

-8.37 (-5.76%)

DNMR Danimer Scientific
$14.72 /

-2.53 (-14.67%)

CVX Chevron
$98.24 /

+2.07 (+2.15%)

CTXS Citrix
$112.49 /

+2.87 (+2.62%)

CP Canadian Pacific
$68.77 /

+0.62 (+0.91%)

CNI Canadian National
$117.29 /

+2.35 (+2.04%)

BNTX BioNTech
$355.75 /

+21.05 (+6.29%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

AMPE Ampio
$1.71 /

+0.255 (+17.53%)

  • 10
    Sep
  • 05
    Aug
  • 25
    Jun
  • 09
    Feb
  • 11
    Dec
YUMC Yum China
$57.59 /

-3.62 (-5.91%)

WMT Walmart
$144.53 /

+0.28 (+0.19%)

WKHS Workhorse Group
$8.22 /

-0.23 (-2.72%)

TROW T. Rowe Price
$214.94 /

+2.02 (+0.95%)

STLD Steel Dynamics
$64.99 /

+3.03 (+4.89%)

SOFI SoFi Technologies
$15.44 /

+0.97 (+6.70%)

PFE Pfizer
$44.77 /

+0.07 (+0.16%)

MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

MGM MGM Resorts
$40.39 /

-1.02 (-2.46%)

LVS Las Vegas Sands
$38.07 /

-0.64 (-1.65%)

LCID Lucid Group
$19.89 /

+0.93 (+4.91%)

KSU Kansas City Southern
$281.68 /

+1.495 (+0.53%)

GS Goldman Sachs
$401.95 /

-2.12 (-0.52%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

F Ford
$13.21 /

+0.35 (+2.72%)

EA Electronic Arts
$137.04 /

-8.37 (-5.76%)

DNMR Danimer Scientific
$14.72 /

-2.53 (-14.67%)

CVX Chevron
$98.24 /

+2.07 (+2.15%)

CTXS Citrix
$112.49 /

+2.87 (+2.62%)

CNI Canadian National
$117.29 /

+2.35 (+2.04%)

BNTX BioNTech
$355.75 /

+21.05 (+6.29%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

YUMC Yum China
$57.59 /

-3.62 (-5.91%)

WKHS Workhorse Group
$8.22 /

-0.23 (-2.72%)

WEBR Weber
$14.92 /

+0.98 (+7.03%)

TBPH Theravance Biopharma
$6.75 /

-1.28 (-15.94%)

STLD Steel Dynamics
$64.99 /

+3.03 (+4.89%)

SOFI SoFi Technologies
$15.44 /

+0.97 (+6.70%)

SE Sea Limited
$337.51 /

+4.18 (+1.25%)

MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

MLCO Melco Resorts & Entertainment
$10.29 /

-1.65 (-13.82%)

MGM MGM Resorts
$40.39 /

-1.02 (-2.46%)

LVS Las Vegas Sands
$38.07 /

-0.64 (-1.65%)

LCID Lucid Group
$19.89 /

+0.93 (+4.91%)

KSU Kansas City Southern
$281.68 /

+1.495 (+0.53%)

JKS JinkoSolar
$48.68 /

+1.94 (+4.15%)

GSKY GreenSky
$11.87 /

+4.1 (+52.77%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

F Ford
$13.21 /

+0.35 (+2.72%)

EA Electronic Arts
$137.04 /

-8.37 (-5.76%)

DNMR Danimer Scientific
$14.72 /

-2.53 (-14.67%)

CVX Chevron
$98.24 /

+2.07 (+2.15%)

CTXS Citrix
$112.49 /

+2.87 (+2.62%)

BNTX BioNTech
$355.75 /

+21.05 (+6.29%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

WYNN Wynn Resorts
$86.44 /

-5.83 (-6.32%)

WMT Walmart
$144.53 /

+0.28 (+0.19%)

WKHS Workhorse Group
$8.22 /

-0.23 (-2.72%)

WEBR Weber
$14.92 /

+0.98 (+7.03%)

TROW T. Rowe Price
$214.94 /

+2.02 (+0.95%)

TBPH Theravance Biopharma
$6.75 /

-1.28 (-15.94%)

STLD Steel Dynamics
$64.99 /

+3.03 (+4.89%)

SOFI SoFi Technologies
$15.44 /

+0.97 (+6.70%)

SKIL Skillsoft
$10.35 /

+0.39 (+3.92%)

SE Sea Limited
$337.51 /

+4.18 (+1.25%)

PFE Pfizer
$44.77 /

+0.07 (+0.16%)

MSFT Microsoft
$304.85 /

+4.96 (+1.65%)

MLCO Melco Resorts & Entertainment
$10.29 /

-1.65 (-13.82%)

MGM MGM Resorts
$40.39 /

-1.02 (-2.46%)

LVS Las Vegas Sands
$38.07 /

-0.64 (-1.65%)

LCID Lucid Group
$19.89 /

+0.93 (+4.91%)

KSU Kansas City Southern
$281.68 /

+1.495 (+0.53%)

JKS JinkoSolar
$48.68 /

+1.94 (+4.15%)

GS Goldman Sachs
$401.95 /

-2.12 (-0.52%)

FB Facebook
$373.92 /

-2.68 (-0.71%)

F Ford
$13.21 /

+0.35 (+2.72%)

EA Electronic Arts
$137.04 /

-8.37 (-5.76%)

DNMR Danimer Scientific
$14.72 /

-2.53 (-14.67%)

CVX Chevron
$98.24 /

+2.07 (+2.15%)

CTXS Citrix
$112.49 /

+2.87 (+2.62%)

CP Canadian Pacific
$68.77 /

+0.62 (+0.91%)

CNI Canadian National
$117.29 /

+2.35 (+2.04%)

AMZN Amazon.com
$3,475.74 /

+25.67 (+0.74%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.